Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Done. urges DEA to put patients first and revise new rules to prevent a nationwide health crisis
  • USA - English


News provided by

Done.

Apr 11, 2023, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Rule changes elevate telehealth in the role of patient-provider medicine but don't go far enough to be relevant to today's hybrid society.

SAN FRANCISCO, April 11, 2023 /PRNewswire-PRWeb/ -- Done., the leading hybrid (in-person + virtual) psychiatric care platform that connects providers to patients with attention-deficit/hyperactivity disorder (ADHD), has expressed concerns through public comments about the Drug Enforcement Administration's (DEA) proposed rule on the Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation. While the ruling is a step in the right direction, in our connected and hybrid world, the rule does not go far enough to preserve and increase patient access to controlled substances for the treatment of substance abuse, mental, and behavioral health issues. This lack of relevancy by the DEA is therefore set to cripple an already-fragile mental-health-patient population.

In this proposed rule, patients are at the risk of being pushed off a telemedicine cliff as the DEA wants to revert to near pre-pandemic policies that require in-person visits with regards to certain medications. Even with a 180-day grace period following when the rules take effect May 11, 2023, the burden remains on the patient to find a provider and with 150 million Americans in what the Health Resources and Services Administration (HRSA) has designated as a "federally designated mental-health professional shortage area" that could mean access to previously prescribed medications is abruptly eliminated.

We believe that the decision to mandate a hybrid model or an in-person visit should fall within the authority of the provider, not as part of a blanket regulatory requirement. This allows providers to better optimize their time by deciding who does and does not need to be seen in person and thus allows the patient to receive effective treatment quickly. The reality is that the vast majority of adults in the U.S. today are experiencing a mental-health crisis - indeed, a mental-health epidemic - and it's now time to make mental-health treatment as ubiquitous as the challenge.

Particularly with ADHD medication, patients who have initiated treatment via telehealth and then for a legitimate reason cannot fulfill the in-person requirement may need to discontinue treatment altogether, potentially leading to a declined quality of life due to low self-esteem, depression, and anxiety. Additional consequences can relate to difficulty in relationships, job instability, negative social interactions, drug and alcohol misuse, and increased mortality rate.

Furthermore, 37% of Americans have almost no access to any of the care they need. Countless individuals do not have access to a mental-health provider as 60% of all counties and 80% of rural counties either have no psychiatrist, may have issues with transportation, and/or may be unable to leave their homes due to their mental illness. These systemic hurdles already force an unfair burden and new measures that require an in-person evaluation will be detrimental to most Americans.

To help solve these critical issues, Done. recommends a hybrid model that can incorporate both the requisite regulations in the industry but also the greatest malleability to meet patient needs. Done. uses technology, data, and insights to improve patient experience and clinical outcomes. Since its founding, Done. has been committed to making the highest quality psychiatric care accessible and affordable. Since our launch in 2019, Done. has set out to be the leader in hybrid psychiatric care through initially focusing on helping patients with ADHD get the care they need.

Hybrid care is defined as a blend of in-person with virtual coverage to provide a holistic option for the patient and provider to achieve the greatest clinical outcomes possible. We achieve this through a "direct" and collaborative care model. We combine Done's ongoing virtual care offering with high-touch in-person care through Done.'s independent partner psychiatric expert clinicians consultations at Done. offices, partner clinician in-person consultations, and trusted provider referrals maximize access to the best psychiatric care available.

Done's mission has always been to empower and support our members in reaching their potential. We started Done. because there was a lack of qualified clinicians to treat patients and because patients struggled to access care within their communities. We remain committed to that mission and urge the DEA to take the necessary actions without delay.

About Done.
Done. is a hybrid-care (in-person + virtual) health platform that empowers anyone living with mental health challenges to reach their fullest potential. Through a patient-first, technology-powered platform, industry-leading digital-health company, Done. makes high-quality psychiatric chronic care management more accessible and affordable.

Disclaimer: Done. is an online platform that connects members with qualified clinicians to screen, diagnose, and treat members with ADHD. Done. does not provide medical services. All professional services on the Done. platform are provided by clinicians who are psychiatric board-certified medical professionals; Done. does not engage in the prescription business. To learn more about the platform, visit: DoneFirst.com.

Media Contact

Gretchen Pahia, Pitch Public Relations, 1 602-309-4286, [email protected]

SOURCE Done.

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.